Search Results For ''

  • Kogan surges on to New Zealand shores with $122m eCommerce acquisition

    Following a proven model that skyrocketed Kogan.com (ASX: KGN) to the top of Australia’s eCommerce market, the online retailer is set to follow a similar path in New Zealand with the acquisition of Mighty Ape and its 895,000 subscribers.  A homegrown retailer in New Zealand, Mighty Ape has built a reputation for its quick delivery

    Read More
    Public
  • Summer oysters trial tipped to increase Angel Seafood sales by 15%

    Seafood-loving Australians could soon have access to a wider range of oysters year-round with Angel Seafood (ASX: AS1) set to commence a farming trial of summer oysters which, if successful, would enable them to deliver oysters throughout the calendar year. The trials are part of Angel Seafood’s recently announced 3-pillar growth strategy to double their

    Read More
    Public
  • Are gold prices bottoming out?

    Much has been made of the sell-off in gold across the past month, with analysts pointing to more certain economic conditions. They suggest that gold has fallen due to several promising COVID-19 vaccines and a resolution to the US election. However, gold has shown greater correlation to policy settings rather than economic uncertainty and the

    Read More
    Public
  • Rhythm Biosciences appoint mass manufacturer for bowel cancer test kits

    Aussie medtech company Rhythm Biosciences (ASX: RHY) is set to improve the screening process of colorectal cancer with manufacturing of their ColoSTAT testing kit to commence shortly after having appointed Biotem Limited as their new global manufacturer. Colorectal cancer is the third biggest cause for cancer deaths globally where current screening processes tend only to

    Read More
    Public
  • Feasibility Study confirms Syrah’s lucrative graphite facility in Louisiana

    Amid the electric vehicle boom and growing desire from US automakers to reduce reliance on China, battery minerals company Syrah Resources (ASX: SYR) has confirmed significantly lower operating costs to supply graphite from their US facility.  The Bankable Feasibility Study (BFS) confirmed the business case for Syrah’s natural graphite Active Anode Material (AAM) production at

    Read More
    Public
  • Genetic Technologies to address mental health with pharmacogenomics AI

    With 1 in 8 Australians suffering from depression, the market for antidepressants is a growing one but one which medical professionals can be assisted to navigate through Genetic Technologies (ASX: GTG) and pharmacogenomics, genomic-based artificial intelligence. The tech will be coming to Australia through a new 3-year distribution agreement with Israel-based Taliaz, the developers of

    Read More
    Public